Literature DB >> 5577129

Effects of progressive desialylation on the rate of disappearance of immunoreactive HCG from plasma in rats.

E V Van Hall, J L Vaitukaitis, G T Ross, J W Hickman, G Ashwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5577129     DOI： 10.1210/endo-89-1-11

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  6 in total

Review 1.  Molecular structures of glycoprotein hormones and functions of their carbohydrate components.

Authors:  A Stockell Hartree; A G Renwick
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

2.  Metabolic labeling of lutropin with [35S]sulfate.

Authors:  G Hortin; M Natowicz; J Pierce; J Baenziger; T Parsons; I Boime
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

3.  Carboxyterminal peptide fragments of the beta subunit are urinary products of the metabolism of desialylated human choriogonadotropin.

Authors:  S Amr; C Rosa; S Birken; R Canfield; B Nisula
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

4.  Binding in vitro to rat liver receptors does not correlate with activities in vivo of bovine somatotropin. Use of chemically modified derivatives as probes.

Authors:  L P Roguin; J M Delfino; N Vita; A C Paladini
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

5.  Asialoagalacto-human chorionic gonadotropin, a carbohydrate-modified variant of human chorionic gonadotropin, antagonizes the stimulatory actions of bovine thyroid-stimulating hormone on thyroid function and HLA-DR expression in human thyroid in vitro and in vivo.

Authors:  R Hoermann; P M Schumm-Draeger; K Rehbach; K Mann
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  The biochemical properties of urinary human chorionic gonadotropin from the patients with trophoblastic disease.

Authors:  R Nishimura; Y Endo; K Tanabe; Y Ashitaka; S Tojo
Journal:  J Endocrinol Invest       Date:  1981 Jul-Sep       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.